Schedule: Monday – Saturday – 0:00 – 0:00, Sunday – 0:00 – 0:00 Individuals and Institutions with an interest in hematological malignancies can become members. pRISM-S Study: Accrual complete, Data validation GLaD Study: Accrual complete, Manuscript writing in-progress Hodgkin’s Study: Accrual complete, follow-up ongoing Hematological Cancer Consortium (HCC) is intended to be a multi-center collaborative academic organization to improve knowledge, standardize cost-effective treatment strategies and